⌘K

Home/Filings/4/0001651844-21-000001

4//SEC Filing

Robinson James George 4

Accession 0001651844-21-000001

CIK 0001018735other

View on SEC.gov Company Profile

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 11:09 AM ET

Size

23.7 KB

Accession

0001651844-21-000001

Insider Transaction Report

Form 4

Period: 2021-04-21

NYMOX PHARMACEUTICAL CORPnymx

Robinson James George

Director

Transactions

Purchase
Common Stock
2021-04-22$2.10/sh+3,100$6,526→ 3,535,550 total
Purchase
Common Stock
2021-04-21$2.08/sh+900$1,870→ 3,523,550 total
Purchase
Common Stock
2021-04-22$2.07/sh+7,000$14,489→ 3,530,550 total
Purchase
Common Stock
2021-04-22$2.05/sh+5,000$10,250→ 3,540,550 total
Purchase
Common Stock
2021-04-22$2.08/sh+51$106→ 3,545,550 total
Purchase
Common Stock
2021-04-22$2.10/sh+800$1,680→ 3,546,350 total
Purchase
Common Stock
2021-04-21$2.09/sh+2,000$4,180→ 3,512,550 total
Purchase
Common Stock
2021-04-21$2.08/sh+6,000$12,480→ 3,518,550 total
Purchase
Common Stock
2021-04-22$2.13/sh+1,900$4,047→ 3,532,450 total
Purchase
Common Stock
2021-04-22$2.09/sh+2,900$6,061→ 3,549,250 total
Purchase
Common Stock
2021-04-22$2.09/sh+1,100$2,297→ 3,550,350 total
Purchase
Common Stock
2021-04-21$2.08/sh+4,100$8,528→ 3,522,650 total
Purchase
Common Stock
2021-04-22$2.09/sh+4,949$10,343→ 3,545,499 total
Purchase
Common Stock
2021-04-22$2.08/sh+200$417→ 3,550,550 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NYMOX PHARMACEUTICAL CORP

CIK 0001018735

Entity typeother

Related Parties

1

filerCIK 0001651844

Filing Metadata

Form type: 4
Filed: Apr 26, 8:00 PM ET
Accepted: Apr 27, 11:09 AM ET
Size: 23.7 KB

View on SEC.gov